Shares of Ranbaxy Laboratories fell over 2 per cent on the bourses after the company said it has suspended shipments of all pharmaceutical ingredients from its Toansa and Dewas plants. “This voluntary decision was taken as a precautionary measure and out of abundant caution to better allow the company to assess and review the processes and controls. The company will resume shipments after reassuring them about the processes and controls at these facilities,” the company said in a filing on Tuesday.
Help employers find you! Check out all the jobs and post your resume.
